Rankings
▼
Calendar
ARVN FY 2022 Earnings — Arvinas, Inc. Revenue & Financial Results | Market Cap Arena
ARVN
Arvinas, Inc.
$907M
FY 2022 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$131M
+145.1% YoY
Gross Profit
$131M
100.0% margin
Operating Income
-$263M
-200.3% margin
Net Income
-$283M
-215.0% margin
EPS (Diluted)
$-5.31
Cash Flow
Operating Cash Flow
-$274M
Free Cash Flow
-$280M
Stock-Based Comp.
$76M
Balance Sheet
Total Assets
$1.3B
Total Liabilities
$704M
Stockholders' Equity
$565M
Cash & Equivalents
$81M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$131M
$54M
+145.1%
Gross Profit
$131M
$54M
+145.1%
Operating Income
-$263M
-$188M
-39.7%
Net Income
-$283M
-$191M
-47.9%
← Q4 2021
All Quarters
Q1 2022 →